Regarding the hematologic and biochemical features of α-thalassemia, all of the following statements are correct EXCEPT:

Explanation

## α-Thalassemia: Genetics, Hemoglobins, and Clinical Features ### Genetic Basis α-thalassemia results from deletion or dysfunction of α-globin genes. Humans have **4 α-globin genes** (2 on each chromosome 16). ### Classification by Gene Deletions | Genotype | Genes Deleted | Clinical Phenotype | Hb Level | MCV | |----------|---------------|-------------------|----------|-----| | **Silent carrier** | 1 | Asymptomatic, normal labs | Normal | Normal | | **α-thal trait** | 2 | Microcytic, hypochromic | Normal or ↓ | ↓↓ | | **HbH disease** | 3 | Hemolytic anemia, splenomegaly | 7–10 g/dL | ↓↓ | | **Hydrops fetalis (Hb Bart's)** | 4 | Intrauterine death | — | — | ### Hemoglobin Composition in α-Thalassemia **When α-globin is deficient, excess β-globin chains form tetramers:** 1. **Hemoglobin H (β~4~)** - Formed in HbH disease (3 α-gene deletion) - Tetrameric β-globin chains with no α-chains - Appears as a **precipitate on supravital staining** (brilliant cresyl blue or new methylene blue) - Forms characteristic "golf ball" appearance under light microscopy - **Functionally unstable** — poor oxygen affinity, causes hemolysis 2. **Hemoglobin Bart's (γ~4~)** - Formed in hydrops fetalis (4 α-gene deletion) - Tetrameric γ-globin chains - Present only in fetal life (γ-chains normally silenced after birth) - **Incompatible with life** — no functional hemoglobin for oxygen transport ### The Critical Error in Option 3 **Option 3 claims β~4~ tetramers "confer a survival advantage over free β-chains."** This is **FALSE** for two reasons: 1. **β~4~ (Hemoglobin H) is functionally unstable and harmful:** - Poor oxygen affinity - Precipitates and causes oxidative damage - Responsible for hemolysis in HbH disease - Does NOT protect — it worsens the phenotype 2. **β~4~ formation is NOT a survival advantage:** - It is a consequence of α-chain deficiency, not an adaptation - Patients with HbH disease still have significant hemolytic anemia - The formation of β~4~ is a **pathologic response**, not a compensatory mechanism **High-Yield:** Do NOT confuse β~4~ (Hemoglobin H) with HbF (fetal hemoglobin, γ~2~α~2~). HbF IS protective in β-thalassemia because it does not require β-chains. β~4~ is NOT protective — it is unstable and hemolytic. ### Correct Statements (Options 0, 1, 2) **Option 0:** ✓ Hemoglobin H appears as a precipitate on supravital staining — classic finding in HbH disease. **Option 1:** ✓ α-thalassemia trait (2-gene deletion) presents with microcytosis (low MCV ~60–70 fL) and hypochromia but hemoglobin is normal or only mildly reduced because the remaining 2 α-genes can still produce some α-chains. **Option 2:** ✓ Hydrops fetalis results from deletion of all 4 α-genes, producing only Hb Bart's (γ~4~), which cannot transport oxygen. This is incompatible with life and results in intrauterine death or severe neonatal distress. ### Mnemonic for α-Thalassemia Severity **"SHHH" (Silent, HbH, Hydrops)** - **S**ilent carrier (1 deletion) — asymptomatic - **H**bH disease (3 deletions) — hemolytic anemia - **H**ydrop**s** fetalis (4 deletions) — lethal